Safety of osimertinib in adult patients with metastatic epidermal growth factor receptor T790M mutation‑positive non‑small cell lung cancer: Results from a Phase IV study in India.

Autor: Malik, Prabhat S.1 drprabhatsm@gmail.com, Noronha, Vanita2, Dabkara, Deepak3, Maddu, Vamshi K.4, Rajappa, Senthil5, Limaye, Sewanti6, Batra, Ullas7
Zdroj: Indian Journal of Cancer. 2022 Supplement, Vol. 59, pS1-S10. 10p.
Databáze: Academic Search Ultimate